Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Sym023 |
Trade Name | |
Synonyms | Sym 023|Sym-023|S095018 |
Drug Descriptions |
Sym023 is monoclonal antibody that targets T-cell immunoglobulin and mucin domain-3 protein (TIM-3, HAVCR2), potentially resulting in enhanced anti-tumor immune response (AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5629). |
DrugClasses | Immune Checkpoint Inhibitor 149 TIM-3 Antibody 9 |
CAS Registry Number | NA |
NCIT ID | C150560 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + Sym023 | Cemiplimab Sym023 | 0 | 1 |
Sym021 + Sym023 | Sym021 Sym023 | 0 | 1 |
Sym023 | Sym023 | 0 | 1 |